PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
34887387-6	2021	Furthermore, we provide the first preclinical evidence demonstrating that combined therapy with a DOT1L inhibitor significantly improves the therapeutic efficacy of etoposide in murine orthotopic xenografts of RB by rendering the response to etoposide more potent and stable.	Etoposide	165-174	DOT1-like, histone H3 methyltransferase (S. cerevisiae)	Mus musculus	98-103	
34887387-6	2021	Furthermore, we provide the first preclinical evidence demonstrating that combined therapy with a DOT1L inhibitor significantly improves the therapeutic efficacy of etoposide in murine orthotopic xenografts of RB by rendering the response to etoposide more potent and stable.	Etoposide	242-251	DOT1-like, histone H3 methyltransferase (S. cerevisiae)	Mus musculus	98-103